• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    The first use of stereotactic ablative body radiotherapy (SABR) in extracranial non-lung oligometastatic disease: a single centre

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Bowen Jones, S C
    Fatimilehin, Abiola
    Hirst, L.
    Hall, R.
    Harris, Catherine
    Whitehurst, Philip
    Croxford, William
    Bayman, Neil A
    Colaco, Rovel J
    Woolf, David K
    Radhakrishna, Ganesh
    Show allShow less
    Affiliation
    The Christie NHS FT Manchester
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Background to the audit: There is evidence that the use of SABR is associated with improved patient outcomes.1 This audit evaluates the first use of SABR through the NHS Commissioning through Evaluation (CtE) programme in patients with extra-cranial, non-lung oligometastatic disease. Standard: The Kings Health Partnership National CtE Report V1.6,2 and the National Cancer Institute (NCI) toxicity grading criteria V5.0.3 Indicator: To evaluate local control (LC) and overall survival (OS) at 12 months, freedom from systemic anti-cancer therapy (SACT) interval and grade 3/4 toxicity. Target: To compare with the National CtE data outcomes (LC 86.8% and OS 92.3% at 12 months).2 Methodology: A retrospective review of all patients treated with SABR between April 2017eSeptember 2019. The inclusion criteria were up to three lesions, each 6c m in size, World Health Organization (WHO) performance status of 2. Results of first audit round: A total of 54 patients were treated and 11 patients had SABR to >1 site. Prescribed doses ranged from 30e60 Gray (Gy) in 3e8 fractions. The median follow up was 12 months. The LC at one year was 94.4% (51/54). The OS rate at one year was 88.8%. In 63% (34/54), there was no evidence of progressive disease during the follow-up period. Of the 37% (20/54) who did have progression, 15% (3/20) had local progression whereas 85% (17/20) had distant progression. The median freedom from SACT interval was 5.9 months (range five dayse17 months). There were no G3/4 toxicity. First action plan: This real-world data reflects the efficacy and safety for SABR in oligometastatic disease. SABR can delay systemic therapy and offer longer treatment free intervals. Updated data with an expanded cohort and assessment of tumour-specific factors will be presented.
    Citation
    Bowen Jones S, Fatimilehin A, Hirst L, Hall R, Harris C, Whitehurst P, et al. The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre. Vol. 34, Clinical Oncology. Elsevier BV; 2022. p. e2–3.
    Journal
    Clinical Oncology
    URI
    http://hdl.handle.net/10541/625258
    DOI
    10.1016/j.clon.2022.01.017
    Additional Links
    https://dx.doi.org/10.1016/j.clon.2022.01.017
    Type
    Meetings and Proceedings
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.clon.2022.01.017
    Scopus Count
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.